Daniel Abdun-Nabi, President & CEO at Emergent BioSolutions Inc. (EBS), sold 20,000 shares at $45.99 ($920K) on 2017-12-13, disclosed to the SEC on 2017-12-14.
Scheduled sale ($920k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EBS | SELL | 2018-09-18 | $1.9M | — | Filing → |
| EBS | SELL | 2018-09-06 | $5.5M | — | Filing → |
| EBS | SELL | 2018-06-07 | $823K | — | Filing → |